The Drug Enforcement Administration this week proposed changing rules that govern the amount of prescription opioids that drug manufacturers can produce each year. The changes could sharply reduce the annual production of opioids, Reuters reports.
The acting chief of the Drug Enforcement Administration told the House Energy and Committee this week the agency is doing a better job of tracking the flow of opioid painkillers from manufacturers to pharmacies, The Washington Post reports.
The Drug Enforcement Administration will classify illicit versions of fentanyl at the same level as heroin, Reuters reports. The action will make it easier for federal prosecutors and agents to prosecute traffickers of all forms of fentanyl-related substances, the agency said.
Chuck Rosenberg, the acting head of the Drug Enforcement Administration, said he will resign at the end of the week, The New York Times reports. Law enforcement officials said Rosenberg has grown disillusioned with President Trump and feels he has little respect for the law.
Two major drug wholesalers recently agreed to pay millions of dollars to settle claims they failed to report suspicious orders for opioid painkillers to the Drug Enforcement Administration, according to NPR.
The head of the Drug Enforcement Administration is visiting China this week to discuss combating sales of synthetic drugs, including fentanyl, CNN reports. Acting Administrator Chuck Rosenberg will also discuss new psychoactive substances and money-laundering activities when he meets with Chinese officials.
In the past year, federal and state policymakers have taken a number of steps to combat synthetic drugs, also known as “novel psychoactive substances,” according to Jonathan Woodruff, Senior Legislative Attorney at the National Alliance for Model State Drug Laws.